Genext Genomics, a leading provider of antibody services, is pleased to announce the availability of its advanced anti-TNF alpha antibody. This antibody is designed to target TNF alpha, a cytokine that is involved in the pathogenesis of several autoimmune diseases, including rheumatoid arthritis, Crohn’s disease, and ulcerative colitis. Contact us now to know more details.
